Private equity firm KKR has acquired Medicover, the Sweden-based international healthcare and diagnostic services provider, in a deal valued at $1.5 billion. The transaction, which will take Medicover private, was confirmed by both parties on Tuesday. Medicover, listed on Nasdaq Stockholm, will delist from the exchange following the completion of the acquisition.
Medicover, founded in 1995 and headquartered in Sweden, operates across 19 countries with a workforce exceeding 48,000 employees. Its largest markets include Poland, Germany, Romania, India, and Ukraine. The company is organized into two primary divisions: Healthcare Services, which covers outpatient clinics, hospitals, specialist care, fertility treatment, dental services, and wellness offerings such as sports packages; and Diagnostic Services, which provides a broad range of clinical laboratory tests, from routine screenings to advanced monitoring.
For KKR, the acquisition represents a significant expansion into the European and Asian healthcare sectors. The firm has been actively investing in healthcare services globally, and Medicover’s integrated model of preventive care and diagnostics aligns with KKR’s focus on scalable, essential services. The deal provides KKR with a platform to support Medicover’s growth in existing markets while potentially entering new geographies where demand for private healthcare is rising.
The acquisition is expected to enable Medicover to accelerate investments in its clinic network and laboratory infrastructure, areas that require substantial capital. As a private entity, Medicover will have greater flexibility to pursue long-term projects without the quarterly reporting pressures of a public listing. KKR’s operational expertise in healthcare is anticipated to assist in optimizing efficiency across Medicover’s diverse operations.
The transaction is subject to regulatory approvals and is expected to close in the coming months. Once finalized, Medicover will continue to operate under its existing brand and management team, with KKR providing strategic and financial backing. The combined focus will be on strengthening Medicover’s position as a leading healthcare provider in its core markets while exploring opportunities for organic and inorganic growth.